Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
JAMA Cardiology|September 17, 2025
Prevention of Adverse Cardiovascular Events Using the 23-Valent Pneumococcal Polysaccharide Vaccine: A Randomized Clinical TrialAlexis Hure, Roseanne Peel, Catherine D'Este, et al.
American Heart Journal|December 13, 2006
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trialHarvey D White, Neal S Kleiman, Kenneth W Mahaffey, et al.
Heart (British Cardiac Society)|January 17, 2025
Transitioning to high-sensitivity troponin: 1-year mortality outcomes in patients with suspected acute coronary syndrome presenting to emergency departmentsSiobhan Hickling, Frank M Sanfilippo, Louise Cullen, et al.
American Heart Journal|February 12, 2026
Design and rationale of A Multicenter Paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock - The PANDA trialJason E Bloom, Jocasta Ball, Daniel Okyere, et al.
JAMA|April 4, 2016
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical TrialSteven E Nissen, Erik Stroes, Ricardo E Dent-Acosta, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 20, 2019
The Asia-Pacific Society of Cardiology (APSC) Expert Committee Consensus Recommendations for Assessment of Suspected Acute Coronary Syndrome Using High-Sensitivity Cardiac Troponin T in the Emergency DepartmentWei Chieh Jack Tan, Kenji Inoue, Laila AbdelWareth, et al.
The American Journal of Cardiology|April 28, 2004
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)A Michael Lincoff, John A Bittl, Neal S Kleiman, et al.
The Medical Journal of Australia|August 1, 2020
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statementSarah Zaman, Andrew I MacIsaac, Garry Lr Jennings, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 26, 2020
Comparative overview of ST-elevation myocardial infarction epidemiology, demographics, management, and outcomes in five Asia-Pacific countries: a meta-analysisPaul Jie Wen Tern, Aaron Kwun Hang Ho, Rehena Sultana, et al.
Circulation|May 9, 2022
Text Messages to Improve Medication Adherence and Secondary Prevention After Acute Coronary Syndrome: The TEXTMEDS Randomized Clinical TrialClara K Chow, Harry Klimis, Aravinda Thiagalingam, et al.
Pageof 24